What Seebreath AB does

Seebreath AB is a Swedish medical device company founded in 2010 and headquartered in Stockholm that develops, manufactures, and sells colorimetric CO2-indicating products used to verify correct endotracheal tube placement and to provide continuous visual monitoring of expired CO2 during mechanical ventilation. Its core technology is an impregnated porous membrane carrying a proprietary dye chemistry that changes color from blue to green to yellow as CO2 concentration rises from 0% to 2% to 5%, enabling caregivers to read breathing status by eye without specialized electronic equipment. The commercial product line consists of the CapnoDura Combi, a CO2 indicator/detector for adults and children over 10 kg with up to 24 hours of continuous indication and up to 25 breaths-per-minute visualization, and the CapnoDura Pedi, a pediatric device for patients 1-15 kg with a 3 ml internal deadspace and up to 40 breaths-per-minute visualization.

The company makes money through two channels: direct sale of its CapnoDura devices to hospitals, emergency medical services, ICUs, and operating rooms worldwide, and licensing of its CO2 indicator technology to other manufacturers for integration into their disposable respiratory care products. Manufacturing is performed at an ISO 13485:2016 certified facility in Malaysia (Certificate EN ISO 13485 2016, Production MedDev Manufact MD 582265 from BSI MY), and the products hold FDA approval and registration for the US market. No pricing is publicly disclosed, no revenue figure is available, no funding rounds have been raised, and the leadership team is limited to two Managing Directors (Erik Lissner and Patrik Tornström) and a Sales and Marketing Manager (Christoffer Andersson). The company positions itself as a technology licensor open to OEM cooperation with manufacturers seeking to add CO2 detection to their own disposable respiratory products.

Name

Seebreath AB

Legal name

Seebreath AB

Website

https://seebreath.com

Company type

Private

Founded year

2010

Operating status

Operating

Short description

Seebreath AB is a Swedish medical device company that develops, manufactures, and sells colorimetric CO2 indicator products — the CapnoDura Combi and CapnoDura Pedi — for verifying endotracheal tube placement and monitoring expired CO2 in hospitals, EMS, and OEMs worldwide.

Ownership category

akta.pro rank

Headquarters

HQ city

Stockholm

HQ country

Sweden

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Medical Device Sales: Sale of proprietary CO2 indicator/detector products including CapnoDura Combi (adult/pediatric) and CapnoDura Pedi. One-time purchase of medical devices for breathing monitoring and intubation verification.
2. Technology Licensing/OEM: Licensing of proprietary colorimetric CO2 indicator technology to other manufacturers for integration into their disposable respiratory care products. Manufacturers gain CO2 detection capability for patient safety enhancement.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels1 record

Core offering

Seebreath AB manufactures and sells colorimetric CO2 indicator products for breathing monitoring, primarily the CapnoDura product line (CapnoDura Combi for adults and children, and CapnoDura Pedi for pediatric use). The company's products visually verify correct endotracheal tube placement through color changes (blue to yellow) corresponding to CO2 concentration, and Seebreath also licenses its proprietary CO2 indicator technology to other manufacturers for integration into disposable respiratory care products.

Product overview

Seebreath AB is a Swedish technology company and technology leader for colorimetric indication of CO2 for breathing monitoring. The company offers a portfolio of medical device products centered on its proprietary CO2 indicator technology, which uses an impregnated porous membrane that changes color based on CO2 concentration. The main products are CapnoDura Combi (for adults and children over 10 kg) and CapnoDura Pedi (for pediatric use, 1-15 kg), both colorimetric CO2 detectors/indicators that verify correct tracheal intubation placement. The Seebreath technology is also available for licensing to other manufacturers who wish to integrate CO2 detection into their own disposable respiratory care products.

Differentiator

Problem solved

Functional benefit

Brands

• CapnoDura: Colorimetric CO2 indicator/detector product line including CapnoDura Combi for adults and children (patients over 10 kg) and CapnoDura Pedi for pediatric use (patients 1-15 kg).

Products and services

• CapnoDura Combi Colorimetric CO2 indicator/detector designed for verifying correct endotracheal tube placement in adults and children over 10 kg. Provides continuous indication of expired CO2 for up to 24 hours with a color change from blue to yellow, supporting breath-to-breath visualization up to 25 breaths per minute, with 16 ml internal deadspace.
• CapnoDura Pedi Colorimetric CO2 detector designed for pediatric use, suitable for patients between 1-15 kg. Supports breath-to-breath visualization up to 40 breaths per minute with a compact internal deadspace of 3 ml, and provides continuous indication of expired CO2 for up to 24 hours.
• Seebreath CO2 Indicator Technology (Licensing/OEM) Proprietary colorimetric CO2 indication technology based on an impregnated porous membrane with unique dye chemistry that changes color from blue to green to yellow as CO2 concentration changes from 0% to 5%. Licensed to other manufacturers for integration into disposable respiratory care products to add CO2 detection functionality at minimal added cost.

Quantifiable outcome

• Up to 40 breaths per minute monitoring capability
• +3 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Philips Healthcare: Broad portfolio of patient monitors and airway management consumables, including capnography solutions. Competes in the intubation verification and continuous CO2 monitoring market that Seebreath addresses with its colorimetric indicators.
• Masimo: Patient monitoring innovator with strong capnography (NomoLine, ISA) and pulse oximetry offerings. Overlaps with Seebreath on respiratory CO2 monitoring and represents both a competitive threat and a potential OEM channel partner.
• Medtronic: Global medical device leader offering Microstream capnography (electronic CO2 monitoring) integrated with patient monitors. Directly competes with Seebreath's colorimetric CO2 indication by offering mainstream electronic alternatives for intubation verification and continuous respiratory monitoring.
• Mindray: Global medical device manufacturer offering patient monitors with integrated mainstream and sidestream CO2 modules. Provides lower-cost electronic capnography alternatives to Seebreath's colorimetric approach in emerging markets.
• Nihon Kohden: Japanese patient monitoring and medical electronics company offering capnography modules within its broader monitor portfolio. Competes with Seebreath on the capnography/intubation verification use case for hospitals.

Emerging players

• Nonin Medical: Specialist in pulse oximetry and capnography devices, including WristOx and LifeSense products. Comparable niche focus on respiratory monitoring with a similar target customer base of EMS and clinical users.

Direct peers

• Dräger: Major manufacturer of anesthesia, ventilation, and patient monitoring equipment including mainstream and mainstream/side-stream capnography modules. Competes with Seebreath's capnography products while also being a candidate OEM partner for integrating Seebreath colorimetric indicators into disposable airway consumables.
• Hamilton Medical: Swiss manufacturer of ventilators and intelligent ventilation accessories, including CO2 sensors. Direct peer in respiratory/capnography monitoring and a candidate OEM partner for embedding Seebreath's colorimetric indicators into consumable circuits.
• Smiths Medical (ICU Medical): Manufacturer of airway management and respiratory care disposables (including Portex and Bivona lines). Highly comparable business model to Seebreath's OEM target segment and a realistic partner/integrator for colorimetric CO2 indicators.
• Intersurgical: European manufacturer of disposable airway management and anesthesia consumables (breathing circuits

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Seebreath AB